Literature DB >> 31071607

Impact of Decolonization Protocols and Recurrence in Pediatric MRSA Skin and Soft-Tissue Infections.

Steven T Papastefan1, Christie Buonpane2, Guillermo Ares1, Beshoy Benyamen2, Irene Helenowski3, Catherine J Hunter4.   

Abstract

BACKGROUND: Methicillin-resistant staphylococcus aureus (MRSA) colonization is associated with the development of skin and soft-tissue infection in children. Although MRSA decolonization protocols are effective in eradicating MRSA colonization, they have not been shown to prevent recurrent MRSA infections. This study analyzed the prescription of decolonization protocols, rates of MRSA abscess recurrence, and factors associated with recurrence.
MATERIALS AND METHODS: This study is a single-institution retrospective review of patients ≤18 y of age diagnosed with MRSA culture-positive abscesses who underwent incision and drainage (I&D) at a tertiary-care children's hospital. The prescription of an MRSA decolonization protocol was recorded. The primary outcome was MRSA abscess recurrence.
RESULTS: Three hundred ninety-nine patients with MRSA culture-positive abscesses who underwent I&D were identified. Patients with previous history of abscesses, previous MRSA infection groin/genital region abscesses, higher number of family members with a history of abscess/cellulitis or MRSA infection, and I&D by a pediatric surgeon were more likely to be prescribed decolonization. Decolonized patients did not have lower rates of recurrence. Recurrence was more likely to occur in patients with previous abscesses, previous MRSA infection, family history of abscesses, family history of MRSA infection, Hispanic ethnicity, and those with fever on admission.
CONCLUSIONS: MRSA decolonization did not decrease the rate of recurrence of MRSA abscesses in our patient cohort. Patients at high risk for MRSA recurrence such as personal or family history of abscess or MRSA infection, Hispanic ethnicity, or fever on admission did not benefit from decolonization.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Abscess; Decolonization; MRSA; Pediatric; SSTI; Staphylococcus

Mesh:

Substances:

Year:  2019        PMID: 31071607      PMCID: PMC6682437          DOI: 10.1016/j.jss.2019.04.040

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  46 in total

Review 1.  Prevention of Recurrent Staphylococcal Skin Infections.

Authors:  C Buddy Creech; Duha N Al-Zubeidi; Stephanie A Fritz
Journal:  Infect Dis Clin North Am       Date:  2015-09       Impact factor: 5.982

2.  Molecular Epidemiology of Recurrent Cutaneous Methicillin-Resistant Staphylococcus aureus Infections in Children.

Authors:  Duha Al-Zubeidi; Carey-Ann D Burnham; Patrick G Hogan; Rachel Collins; David A Hunstad; Stephanie A Fritz
Journal:  J Pediatric Infect Dis Soc       Date:  2013-07-30       Impact factor: 3.164

3.  Hospital-Acquired Methicillin-resistant Staphylococcus aureus Bacteremia Related to Medicare Antibiotic Prescriptions: A State-Level Analysis.

Authors:  Bryce T Fukunaga; Wesley K Sumida; Deborah A Taira; James W Davis; Todd B Seto
Journal:  Hawaii J Med Public Health       Date:  2016-10

4.  Effectiveness of measures to eradicate Staphylococcus aureus carriage in patients with community-associated skin and soft-tissue infections: a randomized trial.

Authors:  Stephanie A Fritz; Bernard C Camins; Kimberly A Eisenstein; Joseph M Fritz; Emma K Epplin; Carey-Ann Burnham; Jonathan Dukes; Gregory A Storch
Journal:  Infect Control Hosp Epidemiol       Date:  2011-09       Impact factor: 3.254

5.  Molecular Characterization of Nasal Methicillin-Resistant Staphylococcus aureus Isolates Showing Increasing Prevalence of Mupirocin Resistance and Associated Multidrug Resistance following Attempted Decolonization.

Authors:  Toney T Poovelikunnel; Paulo E Budri; Anna C Shore; David C Coleman; Hilary Humphreys; Deirdre Fitzgerald-Hughes
Journal:  Antimicrob Agents Chemother       Date:  2018-08-27       Impact factor: 5.191

6.  Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary.

Authors:  Catherine Liu; Arnold Bayer; Sara E Cosgrove; Robert S Daum; Scott K Fridkin; Rachel J Gorwitz; Sheldon L Kaplan; Adolf W Karchmer; Donald P Levine; Barbara E Murray; Michael J Rybak; David A Talan; Henry F Chambers
Journal:  Clin Infect Dis       Date:  2011-02-01       Impact factor: 9.079

Review 7.  Staphylococcus aureus screening and decolonization in orthopaedic surgery and reduction of surgical site infections.

Authors:  Antonia F Chen; Charles B Wessel; Nalini Rao
Journal:  Clin Orthop Relat Res       Date:  2013-03-06       Impact factor: 4.176

8.  Changing epidemiology and management of infectious diseases in US EDs.

Authors:  Amir M Mohareb; Andrea F Dugas; Yu-Hsiang Hsieh
Journal:  Am J Emerg Med       Date:  2016-03-11       Impact factor: 2.469

9.  Randomized, Double-Blind, Placebo-Controlled Study on Decolonization Procedures for Methicillin-Resistant Staphylococcus aureus (MRSA) among HIV-Infected Adults.

Authors:  Amy Weintrob; Ionut Bebu; Brian Agan; Alona Diem; Erica Johnson; Tahaniyat Lalani; Xun Wang; Mary Bavaro; Michael Ellis; Katrin Mende; Nancy Crum-Cianflone
Journal:  PLoS One       Date:  2015-05-27       Impact factor: 3.240

10.  Targeted versus universal decolonization to prevent ICU infection.

Authors:  Susan S Huang; Edward Septimus; Ken Kleinman; Julia Moody; Jason Hickok; Taliser R Avery; Julie Lankiewicz; Adrijana Gombosev; Leah Terpstra; Fallon Hartford; Mary K Hayden; John A Jernigan; Robert A Weinstein; Victoria J Fraser; Katherine Haffenreffer; Eric Cui; Rebecca E Kaganov; Karen Lolans; Jonathan B Perlin; Richard Platt
Journal:  N Engl J Med       Date:  2013-05-29       Impact factor: 91.245

View more
  1 in total

1.  In Vitro and In Vivo Activity of 14-O-[(4,6-Diamino-pyrimidine-2-yl) thioacetyl] Mutilin against Methicillin-Resistant Staphylococcus aureus.

Authors:  Yunxing Fu; Chunqing Leng; Yuan Fan; Xia Ma; Xianghui Li; Xuefei Wang; Zhenghuan Guo; Xiujun Wang; Ruofeng Shang
Journal:  Molecules       Date:  2021-05-28       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.